Connor, Clark & Lunn Investment Management (CC&L)’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.65M | Buy |
157,094
+53,735
| +52% | +$1.59M | 0.02% | 594 |
|
|
2025
Q1 | $3.09M | Buy |
+103,359
| New | +$3.09M | 0.01% | 615 |
|
|
2024
Q2 | – | Sell |
-8,573
| Closed | -$333K | – | 1428 |
|
|
2024
Q1 | $333K | Sell |
8,573
-29,818
| -78% | -$1.16M | ﹤0.01% | 1230 |
|
|
2023
Q4 | $1.18M | Sell |
38,391
-44,151
| -53% | -$1.36M | 0.01% | 816 |
|
|
2023
Q3 | $1.84M | Buy |
82,542
+4,046
| +5% | +$90.4K | 0.01% | 642 |
|
|
2023
Q2 | $1.69M | Buy |
78,496
+36,799
| +88% | +$791K | 0.01% | 652 |
|
|
2023
Q1 | $1M | Buy |
+41,697
| New | +$1M | 0.01% | 713 |
|
|
2022
Q2 | – | Sell |
-18,882
| Closed | -$384K | – | 1066 |
|
|
2022
Q1 | $384K | Buy |
+18,882
| New | +$384K | ﹤0.01% | 830 |
|
|
2019
Q3 | – | Sell |
-10,400
| Closed | -$137K | – | 972 |
|
|
2019
Q2 | $137K | Buy |
+10,400
| New | +$137K | ﹤0.01% | 936 |
|